Suppr超能文献

鲍曼不动杆菌中 PER-1 介导的头孢地尔耐药的结构基础以及头孢地尔与阿维巴坦或多利布坦联用对 PER-1 的协同抑制作用。

Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumannii.

机构信息

Department of Infectious Diseases, Sir Run Run Shaw Hospitalgrid.415999.9, Zhejiang Universitygrid.13402.34 School of Medicine, Hangzhou, China.

Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.

出版信息

Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0082822. doi: 10.1128/aac.00828-22. Epub 2022 Nov 15.

Abstract

Cefiderocol is a novel siderophore cephalosporin that displays activity against Gram-negative bacteria. To establish cefiderocol susceptibility levels of Acinetobacter baumannii strains from China, we performed susceptibility testing and genomic analyses on 131 clinical isolates. Cefiderocol shows high activity against the strains. The production of PER-1 is the key mechanism of cefiderocol resistance. studies predicted that avibactam and durlobactam could inhibit cefiderocol hydrolysis by PER-1, which was confirmed by determining cefiderocol MICs in combination with inhibitors.

摘要

头孢他啶罗是一种新型的铁载体头孢菌素,对革兰氏阴性菌具有活性。为了确定中国鲍曼不动杆菌菌株对头孢他啶罗的敏感性水平,我们对 131 株临床分离株进行了药敏试验和基因组分析。头孢他啶罗对这些菌株表现出很高的活性。PER-1 的产生是头孢他啶罗耐药的关键机制。研究预测,阿维巴坦和杜拉西林可以抑制 PER-1 对头孢他啶罗的水解,这一结论通过测定与抑制剂联合使用的头孢他啶罗 MIC 得到了证实。

相似文献

引用本文的文献

4
Insights into the activity of cefiderocol against PER-2 producing Enterobacterales.对头孢地尔对产PER-2肠杆菌科细菌活性的见解。
Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0172023. doi: 10.1128/aac.01720-23. Epub 2024 May 1.
6
Drug Discovery in the Field of β-Lactams: An Academic Perspective.β-内酰胺类药物研发:学术视角
Antibiotics (Basel). 2024 Jan 8;13(1):59. doi: 10.3390/antibiotics13010059.
10
Novel Antimicrobial Agents for Gram-Negative Pathogens.用于革兰氏阴性病原体的新型抗菌剂。
Antibiotics (Basel). 2023 Apr 16;12(4):761. doi: 10.3390/antibiotics12040761.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验